Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2013-01163 | Registry Identifier | NCI |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This clinical trial studies computed tomography (CT) in diagnosing patients with lung cancer. Diagnostic procedures, such as CT, may help find and diagnose lung cancer.
PRIMARY OBJECTIVES:
I. Conduct a prospective clinical imaging study to quantify the amount of inter- and intra-physician contouring variability on four dimensional (4D) CT, active breathing control (ABC) CT, free breathing CT, and free breathing and ABC cone beam (CB)CT.
II. Quantify the magnitude and distribution of target and organ at risk volume variations between the different imaging modalities.
III. Determine dosimetric changes related to contouring variations for tumor and normal tissue.
OUTLINE:
Patients undergo conventional free breathing CT, 4D CT, ABC CT, ABC CBCT, and free breathing CBCT before undergoing radiation therapy.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Diagnostic (imaging studies) | Experimental | Patients undergo conventional free breathing CT, 4D CT, ABC CT, ABC CBCT, and free breathing CBCT before undergoing radiation therapy. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| computed tomography | Procedure | Undergo conventional free breathing CT |
|
| Measure | Description | Time Frame |
|---|---|---|
| Amount of inter- and intra-physician contouring variability on 4D CT, ABC CT, free breathing CT, and free breathing and ABC CBCT | A two sided t-test with 5% level of significance will be used. | up to 1 week |
| Measure | Description | Time Frame |
|---|---|---|
| Magnitude and distribution of target and organ at risk volume variations between the different imaging modalities | A two sided t-test with 5% level of significance will be used. | up to 1 week |
| Dosimetric changes related to contouring variations for tumor and normal tissue |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Elizabeth Weiss, M.D. | Virginia Commonwealth University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Virginia Commonwealth University/Massey Cancer Center | Richmond | Virginia | 23298 | United States |
Not provided
| ID | Term |
|---|---|
| D008175 | Lung Neoplasms |
| ID | Term |
|---|---|
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 4-dimensional computed tomography | Procedure | Undergo 4D CT |
|
|
| computed tomography | Procedure | Undergo ABC CT |
|
|
| cone-beam computed tomography | Procedure | Undergo ABC CBCT |
|
| cone-beam computed tomography | Procedure | Undergo free breathing CBCT |
|
A two sided t-test with 5% level of significance will be used. |
| up to 1 week |
| D008171 |
| Lung Diseases |
| D012140 | Respiratory Tract Diseases |